Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Eikon Therapeutics (NASDAQ:EIKN) through any online brokerage.
Other companies in Eikon Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Eikon Therapeutics has a consensus price target of $25.00.
The stock price for Eikon Therapeutics (NASDAQ: EIKN) is $7.46 last updated October 9, 2026 at 3:59 PM EDT.
There are no upcoming dividends for Eikon Therapeutics.
Eikon Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Eikon Therapeutics.
Eikon Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.